Alluvi tirzepatide appears to have emerged as a promising therapeutic candidate for the control of metabolic conditions. This exploratory evaluation investigated the efficacy and profile of tirzepatide 40mg in experimental models of type 2 diabetes. The research demonstrated that tirzepatide 40mg substantially improved glycemic control and lowered